Sterling Investment Advisors, Ltd.

Position in PRME — Prime Medicine, Inc.

CIK 1701132 BERWYN, PA

Position in PRME

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$46,632

+$134 QoQ

Shares Held

13,400

0.0% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Sterling Investment Advisors, Ltd. holds $2,227,448 across 4 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	2,947	$1,837,572
2	IMNM	Immunome Inc.	9,918	$210,162
3	REPL	Replimune Group, Inc.	12,300	$136,161
4	ANVS	Annovis Bio, Inc.	23,416	$43,553

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$46,632	13,400	0.0%	Shares	Sole	2026-05-04
2025-12-31	$46,498	13,400	+34.0%	Shares	Sole	2026-02-09
2025-09-30	$55,400	10,000	—	Shares	Sole	2025-10-28
No filing history on record for this holder in this stock.